AstraZeneca beats second-quarter profit expectations, holds outlook

AZN•2026-07-27

Second-quarter profit beats expectations

AstraZeneca topped second-quarter profit expectations and backed its 2026 forecasts on Monday on demand for its cancer and heart disease therapies, as the drugmaker sought to quell concerns over longer-term growth prospects after a recent trial failure.

July 27 (Reuters) - AstraZeneca AZN.L topped second-quarter profit expectations and backed its 2026 forecasts on Monday on demand for its cancer and heart disease therapies, as the drugmaker sought to quell concerns over longer-term growth prospects after a recent trial failure.

AstraZeneca beats second-quarter profit expectations, holds outlook

Second-quarter profit beats expectations

Related News

Argenx To Buy Forte Biosciences For $2.20 Bln

American Express Co <AXP.N>: BTIG cuts target price to $315 from $324

Analysts reaction to Bank Indonesia Governor Perry Warjiyo stepping down

Union Pacific Corp <UNP.N>: Baird Raises Target Price to $344 From $311

Chipmaker CXMT vaults to top of China's valuation with 530% surge in Shanghai debut